Researchers at The Ohio State University Medical Center are partnering with Coriell Institute for Medical Research, one of the world’s leading biomedical research institutions, in the Coriell Personalized Medicine Collaborative (CPMC) study.
Coriell, based in New Jersey, is home to the world’s leading biobank resource for human cells and DNA. The personalized genetics study will recruit and enroll 2,000 participants at Ohio State, free of charge. Ohio State is one of only five centers in the country participating in the project.
“This is a unique opportunity for our community to participate in this ground-breaking national study and move toward wellness-based care that is predictive, preventive, personalized and participatory,” says Clay Marsh, MD, executive director of Ohio State’s Center for Personalized Health Care.
The CPMC creates a protected environment for participants to see and understand their personal genomic information, and allows them to make individualized decisions about their health. This platform will also enable healthcare providers to use the information to develop tailored medical treatments.
“Coriell recognizes The Ohio State University Medical Center’s leadership in personalized health care and how this offers a unique setting for the CPMC study,” says Michael Christman, PhD, president and CEO of the Coriell Institute.